Cargando…
Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation
Phage therapy is an experimental therapeutic approach used to target multidrug-resistant bacterial infections. A lack of reliable data with regard to its efficacy and regulatory hurdles hinders a broad application. Here we report, for the first time, a case of vancomycin-resistant Enterococcus faeci...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472888/ https://www.ncbi.nlm.nih.gov/pubmed/34578366 http://dx.doi.org/10.3390/v13091785 |
_version_ | 1784574850133655552 |
---|---|
author | Paul, Kevin Merabishvili, Maya Hazan, Ronen Christner, Martin Herden, Uta Gelman, Daniel Khalifa, Leron Yerushalmy, Ortal Coppenhagen-Glazer, Shunit Harbauer, Theresa Schulz-Jürgensen, Sebastian Rohde, Holger Fischer, Lutz Aslam, Saima Rohde, Christine Nir-Paz, Ran Pirnay, Jean-Paul Singer, Dominique Muntau, Ania Carolina |
author_facet | Paul, Kevin Merabishvili, Maya Hazan, Ronen Christner, Martin Herden, Uta Gelman, Daniel Khalifa, Leron Yerushalmy, Ortal Coppenhagen-Glazer, Shunit Harbauer, Theresa Schulz-Jürgensen, Sebastian Rohde, Holger Fischer, Lutz Aslam, Saima Rohde, Christine Nir-Paz, Ran Pirnay, Jean-Paul Singer, Dominique Muntau, Ania Carolina |
author_sort | Paul, Kevin |
collection | PubMed |
description | Phage therapy is an experimental therapeutic approach used to target multidrug-resistant bacterial infections. A lack of reliable data with regard to its efficacy and regulatory hurdles hinders a broad application. Here we report, for the first time, a case of vancomycin-resistant Enterococcus faecium abdominal infection in a one-year-old, critically ill, and three times liver transplanted girl, which was successfully treated with intravenous injections (twice per day for 20 days) of a magistral preparation containing two Enterococcus phages. This correlated with a reduction in baseline C-reactive protein (CRP), successful weaning from mechanical ventilation and without associated clinical adverse events. Prior to clinical use, phage genome was sequenced to confirm the absence of genetic determinants conferring lysogeny, virulence or antibiotic resistance, and thus their safety. Using a phage neutralization assay, no neutralizing anti-phage antibodies in the patient’s serum could be detected. Vancomycin-susceptible E. faecium isolates were identified in close relation to phage therapy and, by using whole-genome sequencing, it was demonstrated that vancomycin-susceptible E. faecium emerged from vancomycin-resistant progenitors. Covering a one year follow up, we provide further evidence for the feasibility of bacteriophage therapy that can serve as a basis for urgently needed controlled clinical trials. |
format | Online Article Text |
id | pubmed-8472888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84728882021-09-28 Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation Paul, Kevin Merabishvili, Maya Hazan, Ronen Christner, Martin Herden, Uta Gelman, Daniel Khalifa, Leron Yerushalmy, Ortal Coppenhagen-Glazer, Shunit Harbauer, Theresa Schulz-Jürgensen, Sebastian Rohde, Holger Fischer, Lutz Aslam, Saima Rohde, Christine Nir-Paz, Ran Pirnay, Jean-Paul Singer, Dominique Muntau, Ania Carolina Viruses Article Phage therapy is an experimental therapeutic approach used to target multidrug-resistant bacterial infections. A lack of reliable data with regard to its efficacy and regulatory hurdles hinders a broad application. Here we report, for the first time, a case of vancomycin-resistant Enterococcus faecium abdominal infection in a one-year-old, critically ill, and three times liver transplanted girl, which was successfully treated with intravenous injections (twice per day for 20 days) of a magistral preparation containing two Enterococcus phages. This correlated with a reduction in baseline C-reactive protein (CRP), successful weaning from mechanical ventilation and without associated clinical adverse events. Prior to clinical use, phage genome was sequenced to confirm the absence of genetic determinants conferring lysogeny, virulence or antibiotic resistance, and thus their safety. Using a phage neutralization assay, no neutralizing anti-phage antibodies in the patient’s serum could be detected. Vancomycin-susceptible E. faecium isolates were identified in close relation to phage therapy and, by using whole-genome sequencing, it was demonstrated that vancomycin-susceptible E. faecium emerged from vancomycin-resistant progenitors. Covering a one year follow up, we provide further evidence for the feasibility of bacteriophage therapy that can serve as a basis for urgently needed controlled clinical trials. MDPI 2021-09-07 /pmc/articles/PMC8472888/ /pubmed/34578366 http://dx.doi.org/10.3390/v13091785 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Paul, Kevin Merabishvili, Maya Hazan, Ronen Christner, Martin Herden, Uta Gelman, Daniel Khalifa, Leron Yerushalmy, Ortal Coppenhagen-Glazer, Shunit Harbauer, Theresa Schulz-Jürgensen, Sebastian Rohde, Holger Fischer, Lutz Aslam, Saima Rohde, Christine Nir-Paz, Ran Pirnay, Jean-Paul Singer, Dominique Muntau, Ania Carolina Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation |
title | Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation |
title_full | Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation |
title_fullStr | Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation |
title_full_unstemmed | Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation |
title_short | Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation |
title_sort | bacteriophage rescue therapy of a vancomycin-resistant enterococcus faecium infection in a one-year-old child following a third liver transplantation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472888/ https://www.ncbi.nlm.nih.gov/pubmed/34578366 http://dx.doi.org/10.3390/v13091785 |
work_keys_str_mv | AT paulkevin bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT merabishvilimaya bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT hazanronen bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT christnermartin bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT herdenuta bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT gelmandaniel bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT khalifaleron bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT yerushalmyortal bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT coppenhagenglazershunit bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT harbauertheresa bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT schulzjurgensensebastian bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT rohdeholger bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT fischerlutz bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT aslamsaima bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT rohdechristine bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT nirpazran bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT pirnayjeanpaul bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT singerdominique bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation AT muntauaniacarolina bacteriophagerescuetherapyofavancomycinresistantenterococcusfaeciuminfectioninaoneyearoldchildfollowingathirdlivertransplantation |